Patent ID: 8461184

Claim:
A method for treating at least one disorder in a patient in need thereof, wherein said at least one disorder is chosen from psychosis, anxiety, depression, attention deficits, memory disorders, cognitive disorders, appetite disorders, obesity, addiction, appetence, drug dependence, dementia, dystonia, muscle spasticity, tremor, epilepsy, multiple sclerosis, traumatic brain injury, stroke, Parkinson's disease, Alzheimer's disease, epilepsy, Huntington's disease, Tourette's syndrome, cerebral ischaemia, cerebral apoplexy, craniocerebral trauma, stroke, spinal cord injury, neuroinflammatory disorders, plaque sclerosis, vital encephalitis, demyelinisation related disorders, neuropathic pain disorders, septic shock, glaucoma, diabetes, emesis, nausea, asthma, respiratory diseases, gastrointestinal disorders, gastric, ulcers, diarrhoea, and sexual disorders, said method comprising administering to the patient a pharmacologically effective amount of at least one compound of formula (I), wherein: R 1 represents H, Cl or Br, R 2 represents Cl or Br, X represents a sulphur atom, a sulfoxide (S═O) or a sulfone (SO 2 ) moiety, Y represents a methyl or an ethyl group, and n can have the value 1, 2 or 3, or a tautomer, stereoisomer, prodrug or N-oxide thereof, or a pharmacologically acceptable salt of said compounds of formula (I), or a tautomer, stereoisomer, or N-oxide of any of the foregoing.